Synapse - Mark Kris

Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin

Meeting Abstract

Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

Meeting Abstract

Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations

Meeting Abstract

Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Use of an Internet-based protocol to collect clinical information and blood from patients with lung cancer who never smoked cigarettes

Meeting Abstract

Girard, N.; Klein, R.; Riely, G. J.; Reddy, R.; Kris, M. G.; Pao, W.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Operative outcomes using bevacizumab, docetaxel, and cisplatin as induction therapy in patients with operable lung cancer

Meeting Abstract

Finley, D. J.; Shen, R.; Rizvi, N. A.; Rusch, V. W.; Kris, M. G.; on behalf of the MSKCC Thoracic Disease Management Team
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Rebiopsy of patients (pts) with acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)

Meeting Abstract

Arcila, M. E.; Riely, G. J.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Miller, V. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save